Mary Christine Smith
Director/Board Member at ENDO INTERNATIONAL PLC
Net worth: 20 $ as of 2024-04-29
Mary Christine Smith active positions
Companies | Position | Start | End |
---|---|---|---|
ENDO INTERNATIONAL PLC | Director/Board Member | 2020-07-28 | - |
Independent Dir/Board Member | 2020-07-28 | - | |
ACCENTURE PLC | Human Resources Officer | - | - |
Corporate Officer/Principal | 2020-10-31 | - |
Career history of Mary Christine Smith
Former positions of Mary Christine Smith
Companies | Position | Start | End |
---|---|---|---|
APPLE INC. | Corporate Officer/Principal | 2016-12-31 | 2019-12-31 |
Deloitte & Touche LLP
Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY. | Corporate Officer/Principal | 2000-12-31 | 2016-12-31 |
Training of Mary Christine Smith
Loyola University Maryland, Inc. | Undergraduate Degree |
Rutgers State University of New Jersey | Graduate Degree |
New York University | Doctorate Degree |
Statistics
International
United States | 4 |
Ireland | 3 |
France | 2 |
Operational
Corporate Officer/Principal | 3 |
Director/Board Member | 1 |
Independent Dir/Board Member | 1 |
Sectoral
Consumer Services | 4 |
Health Technology | 2 |
Electronic Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
APPLE INC. | Electronic Technology |
ACCENTURE PLC | Technology Services |
Private companies | 2 |
---|---|
Endo International Plc
Endo International Plc Pharmaceuticals: MajorHealth Technology Endo International Plc operates as a pharmaceutical company, which engages in the development, manufacture, and distribution of branded and generic pharmaceutical products. It operates through the following segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals and International Pharmaceuticals. The Branded Pharmaceuticals segment conducts certain operations in the U.S. through leased and owned manufacturing properties in Pennsylvania, New York and New Jersey, as well as certain administrative and R&D functions through leased properties in Pennsylvania. The Sterile Injectables segment includes manufacturing, quality assurance, research and development, and administration functions. The Generic Pharmaceuticals segment is composed of manufacturing, distribution, quality assurance and administration functions, as well as certain research and development functions. The International Pharmaceuticals segment’s operations are currently conducted through Paladin’s leased headquarters in Montreal, Canada. The company was founded in 1997 and is headquartered Dublin, Ireland. | Health Technology |
Deloitte & Touche LLP
Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY. | Commercial Services |
- Stock Market
- Insiders
- Mary Christine Smith
- Experience